ScoreWhy is Eli Lilly & Co. ?
1
High Management Efficiency with a high ROCE of 33.55%
2
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 21.74
3
Healthy long term growth as Net Sales has grown by an annual rate of 18.34%
4
With a growth in Net Profit of 105.14%, the company declared Very Positive results in Jun 25
- The company has declared positive results for the last 4 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 10,938.2 MM
- ROCE(HY) Highest at 86.7%
- DIVIDEND PER SHARE(HY) Highest at USD 3.52
5
With ROCE of 38.63%, it has a expensive valuation with a 14.99 Enterprise value to Capital Employed
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 27.08%, its profits have risen by 54.2% ; the PEG ratio of the company is 0.9
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Eli Lilly & Co. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Eli Lilly & Co. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Eli Lilly & Co.
22.25%
0.48
40.66%
S&P 500
13.22%
0.64
20.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
18.34%
EBIT Growth (5y)
29.33%
EBIT to Interest (avg)
21.74
Debt to EBITDA (avg)
1.64
Net Debt to Equity (avg)
2.24
Sales to Capital Employed (avg)
0.94
Tax Ratio
18.34%
Dividend Payout Ratio
44.39%
Pledged Shares
0
Institutional Holding
89.11%
ROCE (avg)
33.55%
ROE (avg)
83.66%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
47
Industry P/E
Price to Book Value
46.31
EV to EBIT
38.80
EV to EBITDA
35.51
EV to Capital Employed
14.99
EV to Sales
15.62
PEG Ratio
0.87
Dividend Yield
0.00%
ROCE (Latest)
38.63%
ROE (Latest)
97.65%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Bullish
Bullish
OBV
Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend27What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 10,938.2 MM
ROCE(HY)
Highest at 86.7%
DIVIDEND PER SHARE(HY)
Highest at USD 3.52
INTEREST COVERAGE RATIO(Q)
Highest at 3,011.77
RAW MATERIAL COST(Y)
Fallen by -4.35% (YoY
CASH AND EQV(HY)
Highest at USD 6,766.7 MM
NET SALES(Q)
Highest at USD 15,557.7 MM
OPERATING PROFIT(Q)
Highest at USD 7,499.3 MM
OPERATING PROFIT MARGIN(Q)
Highest at 48.2 %
PRE-TAX PROFIT(Q)
Highest at USD 6,230.1 MM
NET PROFIT(Q)
Highest at USD 5,204.16 MM
EPS(Q)
Highest at USD 6.29
-8What is not working for the Company
INTEREST(HY)
At USD 492.7 MM has Grown at 35.66%
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.06 times
DIVIDEND PAYOUT RATIO(Y)
Lowest at 23.84%
Here's what is working for Eli Lilly & Co.
Interest Coverage Ratio
Highest at 3,011.77
in the last five periodsMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Dividend per share
Highest at USD 3.52 and Grown
In each year in the last five yearsMOJO Watch
Company is distributing higher dividend from profits generated
DPS (USD)
Operating Cash Flow
Highest at USD 10,938.2 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
Highest at USD 15,557.7 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Net Sales
At USD 15,557.7 MM has Grown at 26.99%
over average net sales of the previous four periods of USD 12,250.8 MMMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit
Highest at USD 7,499.3 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at 48.2 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at USD 6,230.1 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD 5,204.16 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD 6.29
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Cash and Eqv
Highest at USD 6,766.7 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -4.35% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Eli Lilly & Co.
Interest
At USD 492.7 MM has Grown at 35.66%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Inventory Turnover Ratio
Lowest at 1.06 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Dividend Payout Ratio
Lowest at 23.84%
in the last five yearsMOJO Watch
Company is distributing lower proportion of profits generated as dividend
DPR (%)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
